OPKO Health

OPKO Health is a fully-integrated healthcare company focused on delivering next-generation solutions for serious diseases across established global markets. With a commitment to innovation, OPKO's management team has unmatched drug development experience that it uses to create leading-edge therapies and diagnostics. Their portfolio includes the clinical laboratory BioReference Laboratories, one of the largest full-service clinical laboratories in the U.S., which serves approximately 11 million patients annually. This extensive network underscores OPKO's ability to provide comprehensive diagnostic testing that meets the needs of various specialties.

The company's research and development efforts prioritize multispecific therapies aimed at addressing the complex drivers of serious conditions such as cancers and infectious diseases. Leveraging partnerships with reputable organizations like Pfizer and Merck, OPKO aims to advance proven technologies to create transformative medicines. FDA-approved treatments such as NGENLA™, a next-generation human growth hormone therapy, highlight OPKO's dedication to providing innovative solutions that improve patient outcomes. The company's vision extends beyond product development; it encompasses a holistic approach to healthcare that integrates diagnostics, therapies, and partnerships to maximize the reach and efficacy of their innovations.